Acutus Medical (NASDAQ:AFIB – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Thursday, Zacks.com reports. According to Zacks, “Acutus Medical Inc. is an arrhythmia management company. It focused on the way cardiac arrhythmias are diagnosed and treated. Acutus Medical Inc. is […]
Brokerages expect that Acutus Medical, Inc. (NASDAQ:AFIB – Get Rating) will post $3.87 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Acutus Medical’s earnings. The highest sales estimate is $3.94 million and the lowest is $3.80 million. Acutus Medical posted sales of $4.71 million […]
Equities research analysts expect Acutus Medical, Inc. (NASDAQ:AFIB – Get Rating) to post earnings of ($0.99) per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Acutus Medical’s earnings. Acutus Medical reported earnings of ($0.97) per share in the same quarter last year, which indicates a negative year over year […]
Equities analysts expect Acutus Medical, Inc. (NASDAQ:AFIB – Get Rating) to report $2.85 million in sales for the current quarter, according to Zacks. Two analysts have issued estimates for Acutus Medical’s earnings. The lowest sales estimate is $2.39 million and the highest is $3.30 million. Acutus Medical reported sales of $3.59 million during the same […]